SELLAS Life Sciences Group, Inc. (SLS) Tops Q3 EPS by 2c

SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) reported Q3 EPS of ($0.06), $0.02 better than the analyst estimate of ($0.08).

For earnings history and earnings-related data on SELLAS Life Sciences Group, Inc. (SLS) click here.

You May Also Be Interested In

• Blue Owl Credit Income Corp caps Q2 tender offer at 5% of shares
• Halliburton (HAL) PT Raised to $40 at UBS: Positive Updated Expected
• Domino's Pizza (DPZ) PT Lowered to $375 at UBS on 'Near-Term Category/Brand Headwinds'